Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026 Cash on hand of approximately […]
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted […]
MKS Instruments Announces Proposed Private Offering of $1.0 Billion of Convertible Senior Notes
ANDOVER, Mass., May 13, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced that it intends to […]
Fortrea Reports First Quarter 2024 Results
For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 million GAAP net loss of $81.6 […]
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update Landmark deal announced with Takeda for ACI-24.060 […]
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease Takeda […]
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
First 14 participants with at least six months of follow up continue to demonstrate sustained improvements in blood glucose and […]
RadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024
LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic […]
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
― Sanofi receives exclusive rights to commercialize losmapimod in all territories outside the U.S.; Fulcrum retains full U.S. commercialization rights […]
Here’s a Crazy And Clever Marketing Idea: Clothes That Actually Fit
CANTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (Nasdaq: DXLG), the largest integrated commerce specialty retailer […]
